Mar 15, 2025

Featuring perspectives from Dr Thomas E Hutson, Dr Rana R McKay, Dr Sumanta Kumar Pal and Dr Tian Zhang, moderated by Dr Pal, including the following topics:

• Introduction (0:00)
• Immunotherapeutic Strategies for Localized and Metastatic Clear Cell Renal Cell Carcinoma (RCC) — Dr Hutson (2:34)
• Optimal Management of...

Mar 7, 2025

Featuring perspectives from Dr Terence Friedlander and Dr Matthew D Galsky, Dr Neeraj Agarwal and Dr Andrew J Armstrong, moderated by Dr Elisabeth I Heath, including the following topics:

• Introduction (0:00)
• Role of Antibody-Drug Conjugates (ADCs) in Front-Line Therapy for Metastatic Urothelial Bladder Cancer...

Aug 30, 2024

Featuring a slide presentation and related discussion from Dr Michiel van der Heijden, including the following topics:

• Efficacy and safety data from the Phase III EV-302/KEYNOTE-A39 trial comparing enfortumab vedotin/pembrolizumab to chemotherapy for patients with previously untreated metastatic urothelial bladder...

Aug 30, 2024

Featuring an interview with Dr Michiel van der Heijden, including the following topics:

• Underlying biological mechanisms of the bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition (0:00)
• Treatment patterns and survival outcomes for patients admitted to the intensive care...

Jul 18, 2024

Featuring perspectives from Dr Rana R McKay and Prof Thomas Powles, including the following topics:

• Introduction (0:00)
• Management of Metastatic Clear Cell Renal Cell Carcinoma (RCC) — Prof Powles (12:39)
• Treatment Approaches for Nonmetastatic RCC; Optimal Care of Patients with Non-Clear Cell RCC — Dr McKay (49:27)